View Older Stories
-
H.C. Wainwright Reiterates Buy Rating on Collegium Pharmaceutical (COLL)
-
H.C. Wainwright Reiterates Buy Rating on Trevi Therapeutics (TRVI)
-
Trevi Therapeutics (TRVI) PT Raised to $12.50 at H.C. Wainwright
-
Jazz Pharmaceuticals (JAZZ) PT Raised to $217 at H.C. Wainwright
-
Xeris Pharmaceuticals (XERS) PT Raised to $8 at H.C. Wainwright
-
H.C. Wainwright Reiterates Buy Rating on Avadel Pharmaceuticals (AVDL)
-
Pacira Pharmaceuticals (PCRX) PT Raised to $48 at H.C. Wainwright
-
H.C. Wainwright Reiterates Buy Rating on Tarsus Pharmaceuticals (TARS)
-
H.C. Wainwright Reiterates Buy Rating on Grace Therapeutics (GRCE)
-
Tarsus Pharmaceuticals (TARS) PT Raised to $73 at H.C. Wainwright
-
Avadel Pharmaceuticals (AVDL) PT Lowered to $25 at H.C. Wainwright
-
H.C. Wainwright Reiterates Buy Rating on ANI Pharmaceuticals (ANIP)
-
Xeris Pharmaceuticals (XERS) PT Raised to $6.60 at H.C. Wainwright
-
H.C. Wainwright Reiterates Buy Rating on Trevi Therapeutics (TRVI)
-
H.C. Wainwright Reiterates Buy Rating on Avadel Pharmaceuticals (AVDL)
-
H.C. Wainwright Reiterates Buy Rating on Zevra Therapeutics, Inc. (ZVRA)
-
H.C. Wainwright Reiterates Buy Rating on Acasti Pharma (ACST)
-
Zevra Therapeutics, Inc. (ZVRA) PT Raised to $20 at H.C. Wainwright
-
H.C. Wainwright Reiterates Buy Rating on ANI Pharmaceuticals (ANIP)
-
Collegium Pharmaceutical (COLL) PT Raised to $50 at H.C. Wainwright
-
H.C. Wainwright Reiterates Buy Rating on Avadel Pharmaceuticals (AVDL)
-
Pacira Pharmaceuticals (PCRX) PT Lowered to $39 at H.C. Wainwright
-
H.C. Wainwright Reiterates Buy Rating on Zevra Therapeutics, Inc. (ZVRA)
-
H.C. Wainwright Reiterates Buy Rating on Pacira Pharmaceuticals (PCRX)
-
ANI Pharmaceuticals (ANIP) PT Raised to $94 at H.C. Wainwright
-
Verrica Pharmaceuticals (VRCA) PT Raised to $14 at H.C. Wainwright
-
Tarsus Pharmaceuticals (TARS) PT Raised to $61 at H.C. Wainwright
-
ANI Pharmaceuticals (ANIP) PT Raised to $87 at H.C. Wainwright
-
Avadel Pharmaceuticals (AVDL) PT Raised to $27 at H.C. Wainwright
-
H.C. Wainwright Starts Acasti Pharma (ACST) at Buy
-
Satsuma Pharmaceuticals (STSA) PT Raised to $18 at H.C. Wainwright
-
UPDATE: H.C. Wainwright Starts ANI Pharmaceuticals (ANIP) at Buy
-
UPDATE: H.C. Wainwright Starts Tarsus Pharmaceuticals (TARS) at Buy
-
Collegium Pharmaceutical (COLL) PT Lowered to $26 at H.C. Wainwright, Following Earnings
-
UPDATE: H.C. Wainwright Downgrades BioDelivery Sciences International (BDSI) to Neutral
-
UPDATE: H.C. Wainwright Starts Xeris Pharmaceuticals (XERS) at Buy
-
UPDATE: H.C. Wainwright Downgrades Taiwan Liposome Co Ltd. (TLC) to Neutral
-
UPDATE: H.C. Wainwright Starts Sterling Financial (STSA) at Buy
-
Pacira Pharmaceuticals (PCRX) PT Raised to $68 at H.C. Wainwright
-
Verrica Pharmaceuticals (VRCA) PT Lowered to $18 at H.C. Wainwright
-
UPDATE: H.C. Wainwright Starts Avadel Pharmaceuticals (AVDL) at Buy
-
Menlo Therapeutics (MNLO) Estimates Raised at H.C. Wainwright
-
Lipocine Inc (LPCN) PT Raised to $3 at H.C. Wainwright Following NDA Resubmission for Tlando Oral TRT
-
Menlo Therapeutics (MNLO) PT Raised to $2.50 at H.C. Wainwright
-
Taiwan Liposome Co Ltd. (TLC) PT Raised to $11 at H.C. Wainwright
-
UPDATE: H.C. Wainwright Starts Menlo Therapeutics (MNLO) at Buy
-
UPDATE: H.C. Wainwright Starts Otonomy (OTIC) at Buy
-
Cara Therapeutics (CARA) PT Lowered to $30 at H.C. Wainwright
-
Cara Therapeutics (CARA) PT Raised to $31 at H.C. Wainwright
-
Cara Therapeutics (CARA) PT Raised to $28 at H.C. Wainwright

